15 Results for "

KMO

" in MedChemExpress (MCE) Product Catalog:
Products (15)

15 Results for "KMO" in MCE Product Catalog:

  • Targets Recommended:
2
2 Cited Publications
Cat. No.: HY-112179
CAS No.: 1799725-26-0
Purity:  99.04%
Target:  

KMO

Research Areas:  

Inflammation/Immunology

GSK180 is a selective, competitive, and potent inhibitor of kynurenine-3-monooxygenase (KMO), a key enzyme of tryptophan metabolism (IC50, ~6 nM), but shows negligible activity against other enzymes on the tryptophan pathway. GSK180 rapidly changes levels of kynurenine pathway metabolites, and acts as a useful tool to probe the therapeutic potential of KMO inhibition .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-15600
CAS No.: 213400-34-1
Purity:  99.87%
Research Areas:  

Neurological Disease

UPF-648 is a potent kynurenine 3-monooxygenase (KMO) inhibitor; exhibits highly active at 1 uM (81 ± 10% KMO inhibition); ineffective at blocking KAT activity.
loading...
    loading...
Cat. No.: HY-119171
CAS No.: 1953157-39-5
Purity:  99.80%
Target:  

KMO

GSK 366 is a type II kynurenine-3-monooxygenase (KMO) inhibitor with IC50 values of 2.3 nM and 0.7 nM for human KMO and P. fluorescens-KMO (Pf-KMO). GSK 366 binds to KMO’s substrate site, prevents productive NADPH association, substrate binding, and FAD hydroperoxy species formation. GSK 366 does not stimulate hydrogen peroxide (H2O2) production and reduces H2O2 levels. GSK 366 can be used for the researches of inflammation and neurological disease, such as acute pancreatitis multiple organ dysfunction syndrome and Alzheimer’s disease .
loading...
    loading...
Cat. No.: HY-W748591
CAS No.: 76735-57-4
Cannflavin A can be isolated from Cannabis sativa L.. Cannflavin A has anti-cancer, neuroprotective and anti-inflammatory activity. Cannflavin A inhibits 1-42 aggregation. Cannflavin A also inhibits kynurenine-3-monooxygenase (KMO) (IC50 = 29.4 μM). Cannflavin A activates apoptosis via caspase-3 cleavage. Cannflavin A exerts anti-inflammatory effects by inhibiting pro-inflammatory enzymes, including prostaglandin E2 and cytochrome c oxidases I and II in PC12 cell line .
loading...
    loading...
Cat. No.: HY-15500
CAS No.: 1008119-83-2
Target:  

KMO

Research Areas:  

Neurological Disease

JM6 is a weak kynurenine 3-monooxygenase (KMO) inhibitor with an IC50 of 19.85 μM for mouse KMO. JM6 can be used for Alzheimer's diseases research .
loading...
    loading...
Cat. No.: HY-RS07400
Research Areas:  

Others

KMO Human Pre-designed siRNA Set A contains three designed siRNAs for KMO gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-182692
CAS No.: 1953156-92-7
Target:  

KMO

Research Areas:  

Inflammation/Immunology

KMO-IN-1 is a KMO inhibitor with a mean pIC50 of 8.5 against KMO. KMO-IN-1 can be used in the research of acute pancreatitis .
loading...
    loading...
Cat. No.: HY-W748591R
CAS No.: 76735-57-4
Cannflavin A (Standard) is the analytical standard of Cannflavin A. This product is intended for research and analytical applications. Cannflavin A can be isolated from Cannabis sativa L.. Cannflavin A has anti-cancer, neuroprotective and anti-inflammatory activity. Cannflavin A inhibits 1-42 aggregation. Cannflavin A also inhibits kynurenine-3-monooxygenase (KMO) (IC50 = 29.4 μM). Cannflavin A activates apoptosis via caspase-3 cleavage. Cannflavin A exerts anti-inflammatory effects by inhibiting pro-inflammatory enzymes, including prostaglandin E2 and cytochrome c oxidases I and II in PC12 cell line .
loading...
    loading...
Cat. No.: HY-15600B
CAS No.: 1465017-87-1
Research Areas:  

Neurological Disease

UPF-648 sodium salt is an effective inhibitor of kynurenine 3-monooxygenase (KMO), achieving approximately 81% inhibition at a concentration of 1uM, with no inhibitory effect on kynurenine aminotransferase (KAT).
loading...
    loading...
Cat. No.: HY-RS18737
Research Areas:  

Others

Kmo Mouse Pre-designed siRNA Set A contains three designed siRNAs for Kmo gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS25224
Research Areas:  

Others

Kmo Rat Pre-designed siRNA Set A contains three designed siRNAs for Kmo gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P704040
Purity:  ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: KMO; Kynurenine 3-Monooxygenase (Kynurenine 3-Hydroxylase); Kynurenine 3-Monooxygenase; DJ317G22.1; Kynurenine 3-Hydroxylase
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-117086
CAS No.: 1953156-61-0
Target:  

KMO

Research Areas:  

Inflammation/Immunology

GSK065 is a KMO inhibitor with an IC50 of 2.5 nM and a Ki of 0.05 nM. GSK065 prevents the effective binding of NADPH to its substrate. GSK065 can be used in studies related to multiple organ dysfunction syndrome associated with acute pancreatitis .
loading...
    loading...
Cat. No.: HY-181988
Target:  

Caspase KMO GSK-3

Research Areas:  

Neurological Disease

DTB-acid is a multi-target inhibitor that binds stably to Caspase-6, KMO and GSK-3β. DTB-acid is applicable to the research of Huntington's disease .
loading...
    loading...
Cat. No.: HY-182456
CAS No.: 1426319-74-5
Target:  

KMO

Research Areas:  

Neurological Disease

CHDI-340246 is an orally active kynurenine monooxygenase (KMO) inhibitor. CHDI-340246 blocks KMO activity, alters the metabolic flux of the kynurenine pathway, inhibits the production of 3-hydroxykynurenine and quinolinic acid, elevates the levels of kynurenine and kynurenic acid, and restores electrophysiological abnormalities in transgenic mouse models of Huntington's disease. CHDI-340246 can be used in studies related to Huntington's disease .
loading...
    loading...
  • 1